loading page

DNMT1 as a marker of increased expression of DNA methyltransferases in lung large-cell neuroendocrine carcinoma patients
  • +4
  • Adam Put,
  • Katerina Smesny Trtkova,
  • Marcel Mittak,
  • Petra Herentinova,
  • Jana Vaculova,
  • Radoslava Cernekova,
  • Jozef Skarda
Adam Put
Ostravska univerzita Lekarska fakulta

Corresponding Author:[email protected]

Author Profile
Katerina Smesny Trtkova
Ostravska univerzita Lekarska fakulta
Author Profile
Marcel Mittak
Ostravska univerzita Lekarska fakulta
Author Profile
Petra Herentinova
Univerzita Palackeho v Olomouci Lekarska fakulta
Author Profile
Jana Vaculova
Ostravska univerzita Lekarska fakulta
Author Profile
Radoslava Cernekova
Ostravska univerzita Lekarska fakulta
Author Profile
Jozef Skarda
Ostravska univerzita Lekarska fakulta
Author Profile

Abstract

This is the first study evaluating expression profile of DNMT1, DNMT3A and DNMT3B genes in lung large cell neuroendocrine carcinoma patients. Large cell neuroendocrine carcinoma is a subtype of non-small-cell lung carcinoma with unknown methylation characteristics, including enzyme activities of DNA methyltransferases. We performed quantitative expression analyzes of DNMT1, DNMT3A and DNMT3B genes on formalin-fixed, paraffin-embedded tissue samples of lung large cell neuroendocrine carcinoma patients, and overexpression of DNMT1 and an increased normalized expression of both DNMT3A and DNMT3B genes relative to matched normal lung tissue were found. In conclusion, we assume that further experiments should be focused on the detection of individual DNMT3B isoforms in patients with this type of non-small cell lung carcinoma.
30 Sep 2024Submitted to Cancer Reports
17 Oct 2024Submission Checks Completed
17 Oct 2024Assigned to Editor
17 Oct 2024Review(s) Completed, Editorial Evaluation Pending
28 Oct 2024Reviewer(s) Assigned